Clinical Trial

Live Double Combined Lactobacillus Capsule for Vaginal Use(IIb)

Study acronym: BV
Completed Phase 2
View on ClinicalTrials.gov →
Summary
This is a multicenter, randomized, double-blind, placebo-controlled phase IIb clinical study, to evaluate the efficacy and safety of the dual - live Lactobacilli-containing vaginal capsule for the treatment of bacterial vaginosis.
Trial Details
NCT Number NCT07418918
Lead Sponsor Guangdong Longchuangji Pharmaceutical Co., Ltd.
Conditions Bacterial Vaginosis
Enrollment 66 participants
Start Date 2023-01-03
Primary Completion 2023-09-01 (estimated)
Study Completion 2023-11-11 (estimated)
Updated on ClinicalTrials.gov 2026-02-18